Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Helix
  4. Epigenetic Clock Algorithms

Epigenetic Clock Algorithms

Machine learning models estimating biological age from methylation signatures.
Back to HelixView interactive version

Epigenetic clock algorithms are machine learning models that estimate biological age (how old a person's cells and tissues are, as opposed to chronological age) by analyzing DNA methylation patterns, which change predictably with age. These algorithms, trained on large cohorts with methylation data, are now integrating additional data from proteomics and metabolomics to provide more accurate, organ-specific age estimates that can assess the aging status of different tissues. Longevity clinics are embedding these clocks into diagnostic workflows to track the efficacy of anti-aging interventions and stratify clinical trial participants based on biological age.

This innovation addresses the need for objective measures of biological aging, where chronological age doesn't accurately reflect health status or aging rate. By providing accurate biological age estimates, these algorithms enable assessment of aging interventions and identification of individuals who are aging faster or slower than expected. Companies like Elysium Health, TruDiagnostic, and research institutions are developing and using these algorithms.

The technology is particularly valuable for longevity research and anti-aging interventions, where measuring biological age provides an objective way to assess effectiveness. As the technology improves and becomes more accessible, it could become a standard health metric. However, ensuring accuracy, understanding what biological age means clinically, and standardizing measurements remain challenges. The technology represents an important tool for aging research and personalized health, but requires continued development to achieve the accuracy and clinical utility needed for widespread use. Success could enable better assessment of aging interventions and personalized health optimization, but the field is still developing and requires more research to understand optimal applications and clinical significance.

TRL
6/9Demonstrated
Impact
4/5
Investment
4/5
Category
Software

Related Organizations

Altos Labs logo
Altos Labs

United States · Research Lab

95%

Biotechnology company focused on cellular rejuvenation programming.

Researcher
Clock Foundation logo
Clock Foundation

United States · Nonprofit

95%

Non-profit organization co-founded by Steve Horvath to advance epigenetic age research and validate clock algorithms.

Developer
University of California, Los Angeles (UCLA)

United States · University

95%

A public land-grant research university in Los Angeles, California.

Researcher
Deep Longevity logo
Deep Longevity

HK · Company

90%

Develops deep learning biomarkers of aging (aging clocks).

Developer
TruDiagnostic logo
TruDiagnostic

United States · Company

90%

Epigenetic testing company focused on aging algorithms.

Developer
Yale University logo
Yale University

United States · University

90%

A private Ivy League research university in New Haven, Connecticut.

Researcher
Elysium Health logo
Elysium Health

United States · Company

85%

Consumer health company focused on aging research and supplements.

Deployer
Zymo Research logo
Zymo Research

United States · Company

85%

A biotechnology company providing research tools for epigenetics and DNA/RNA purification.

Developer
Chronomics

United Kingdom · Company

80%

A bio-infrastructure platform enabling diagnostics and biomarker testing.

Developer
Foxo Technologies logo
Foxo Technologies

United States · Company

80%

A company commercializing epigenetic biomarkers for the life insurance industry.

Deployer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Software
Software
Multi-Omic Foundation Models for Aging Clocks

Large models integrating methylome, proteome, and metabolome to estimate biological age.

TRL
7/9
Impact
5/5
Investment
4/5
Applications
Applications
Cellular Rejuvenation via Epigenetic Editing

Targeted editors restoring youthful epigenetic patterns.

TRL
5/9
Impact
5/5
Investment
4/5
Software
Software
In-Silico Longevity Drug Repurposing Engines

AI platforms identifying geroprotective properties in existing non-longevity drugs.

TRL
8/9
Impact
4/5
Investment
3/5
Applications
Applications
Precision Longevity Interventions

Personalized stacks of therapeutics and lifestyle modifications.

TRL
7/9
Impact
4/5
Investment
4/5
Applications
Applications
Senolytics for Aging

Drug programs clearing senescent cells to delay multi-system decline.

TRL
5/9
Impact
5/5
Investment
4/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions